WO2000046344A3 - Non-stochastic generation of genetic vaccines and enzymes - Google Patents
Non-stochastic generation of genetic vaccines and enzymes Download PDFInfo
- Publication number
- WO2000046344A3 WO2000046344A3 PCT/US2000/003086 US0003086W WO0046344A3 WO 2000046344 A3 WO2000046344 A3 WO 2000046344A3 US 0003086 W US0003086 W US 0003086W WO 0046344 A3 WO0046344 A3 WO 0046344A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- enzymes
- genetic vaccines
- stochastic
- provides methods
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 108090000790 Enzymes Proteins 0.000 title abstract 3
- 102000004190 Enzymes Human genes 0.000 title abstract 3
- 230000002068 genetic effect Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 7
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000002703 mutagenesis Methods 0.000 abstract 1
- 231100000350 mutagenesis Toxicity 0.000 abstract 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/11—Exodeoxyribonucleases producing 5'-phosphomonoesters (3.1.11)
- C12Y301/11002—Exodeoxyribonuclease III (3.1.11.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL138206A IL138206A (en) | 1999-02-04 | 2000-02-04 | Methods for non-stochastic generation of progeny polypeptides and hybrid polynucleotides |
MXPA00009723A MXPA00009723A (en) | 1999-02-04 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes. |
JP2000597406A JP2003524392A (en) | 1999-02-04 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes |
CA002325351A CA2325351C (en) | 1999-02-04 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes |
AU34839/00A AU3483900A (en) | 1999-02-04 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes |
EP00913378A EP1073710A4 (en) | 1999-02-04 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes |
US10/151,469 US20030219752A1 (en) | 1995-12-07 | 2002-05-17 | Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/246,178 | 1999-02-04 | ||
US09/246,178 US6171820B1 (en) | 1995-12-07 | 1999-02-04 | Saturation mutagenesis in directed evolution |
US09/267,118 | 1999-03-09 | ||
US09/267,860 | 1999-03-26 | ||
US09/332,835 | 1999-06-14 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/012239 Continuation-In-Part WO1998001581A1 (en) | 1996-07-09 | 1997-07-09 | Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process |
US10/151,469 Continuation-In-Part US20030219752A1 (en) | 1995-12-07 | 2002-05-17 | Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000046344A2 WO2000046344A2 (en) | 2000-08-10 |
WO2000046344A3 true WO2000046344A3 (en) | 2000-12-28 |
Family
ID=22929614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/003086 WO2000046344A2 (en) | 1995-12-07 | 2000-02-04 | Non-stochastic generation of genetic vaccines and enzymes |
Country Status (5)
Country | Link |
---|---|
US (1) | US6171820B1 (en) |
JP (2) | JP2003524392A (en) |
AU (1) | AU3483900A (en) |
CA (1) | CA2325351C (en) |
WO (1) | WO2000046344A2 (en) |
Families Citing this family (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6740506B2 (en) * | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
US6764835B2 (en) * | 1995-12-07 | 2004-07-20 | Diversa Corporation | Saturation mutageneis in directed evolution |
US6713279B1 (en) | 1995-12-07 | 2004-03-30 | Diversa Corporation | Non-stochastic generation of genetic vaccines and enzymes |
US20030219752A1 (en) * | 1995-12-07 | 2003-11-27 | Diversa Corporation | Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
US6939689B2 (en) | 1995-12-07 | 2005-09-06 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US20070009930A1 (en) * | 1996-12-18 | 2007-01-11 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
CA2276064C (en) | 1997-01-17 | 2013-12-17 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
US7148054B2 (en) * | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
US6159688A (en) | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods of producing polynucleotide variants |
WO1999021977A1 (en) * | 1997-10-24 | 1999-05-06 | Life Technologies, Inc. | Recombinational cloning using nucleic acids having recombination sites |
DK1036198T3 (en) | 1997-12-08 | 2013-01-02 | California Inst Of Techn | Method for Preparation of Polynucleotide and Polypeptide Sequences |
US6541011B2 (en) | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
US7390619B1 (en) * | 1998-02-11 | 2008-06-24 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
BR9910174A (en) | 1998-05-01 | 2001-03-06 | Maxygen Inc | Process for obtaining an optimized recombinant gene for pest resistance, library, and process for obtaining an organism that is pathogenic to a vegetable pest |
US7153655B2 (en) * | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
US20030092023A1 (en) * | 1998-08-12 | 2003-05-15 | Daniel Dupret | Method of shuffling polynucleotides using templates |
US20030104417A1 (en) * | 1998-08-12 | 2003-06-05 | Proteus S.A. | Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
US6991922B2 (en) * | 1998-08-12 | 2006-01-31 | Proteus S.A. | Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation |
US6951719B1 (en) | 1999-08-11 | 2005-10-04 | Proteus S.A. | Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained |
ATE439437T1 (en) * | 1999-01-05 | 2009-08-15 | Univ Boston | IMPROVED CLONING PROCESS |
US20040005673A1 (en) * | 2001-06-29 | 2004-01-08 | Kevin Jarrell | System for manipulating nucleic acids |
AU2415200A (en) * | 1999-01-18 | 2000-08-01 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
US20070065838A1 (en) * | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US20090130718A1 (en) * | 1999-02-04 | 2009-05-21 | Diversa Corporation | Gene site saturation mutagenesis |
JP3399518B2 (en) * | 1999-03-03 | 2003-04-21 | インターナショナル・ビジネス・マシーンズ・コーポレーション | Semiconductor structure and method of manufacturing the same |
US6365377B1 (en) | 1999-03-05 | 2002-04-02 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
US20040002474A1 (en) * | 1999-10-07 | 2004-01-01 | Maxygen Inc. | IFN-alpha homologues |
AU1456101A (en) | 1999-11-03 | 2001-05-14 | Maxygen, Inc. | Antibody diversity generation |
US7115712B1 (en) * | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
US20010039014A1 (en) * | 2000-01-11 | 2001-11-08 | Maxygen, Inc. | Integrated systems and methods for diversity generation and screening |
AU2001241939A1 (en) * | 2000-02-28 | 2001-09-12 | Maxygen, Inc. | Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
WO2001073000A2 (en) * | 2000-03-24 | 2001-10-04 | Maxygen, Inc. | Methods for modulating cellular and organismal phenotypes |
US6479262B1 (en) | 2000-05-16 | 2002-11-12 | Hercules, Incorporated | Solid phase enzymatic assembly of polynucleotides |
EP1297146A2 (en) * | 2000-06-23 | 2003-04-02 | Maxygen, Inc. | Novel chimeric promoters |
WO2002000717A2 (en) | 2000-06-23 | 2002-01-03 | Maxygen, Inc. | Novel co-stimulatory molecules |
WO2002004629A2 (en) * | 2000-07-07 | 2002-01-17 | Maxygen, Inc. | Molecular breeding of transposable elements |
US6858422B2 (en) * | 2000-07-13 | 2005-02-22 | Codexis, Inc. | Lipase genes |
WO2002008408A2 (en) * | 2000-07-21 | 2002-01-31 | Trustees Of Boston University | Modular vector systems |
US7435562B2 (en) * | 2000-07-21 | 2008-10-14 | Modular Genetics, Inc. | Modular vector systems |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
US20020132308A1 (en) * | 2000-08-24 | 2002-09-19 | Mpep @ Page 300-M | Novel constructs and their use in metabolic pathway engineering |
JP2002083691A (en) * | 2000-09-06 | 2002-03-22 | Sharp Corp | Active matrix driven organic led display unit and its manufacturing method |
US6958213B2 (en) * | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
US20020146732A1 (en) * | 2001-02-02 | 2002-10-10 | Padgett Hal S. | Method of increasing complementarity in a heteroduplex |
US20030036854A1 (en) * | 2001-02-06 | 2003-02-20 | The Penn State Research Foundation | Apparatus and method for designing proteins and protein libraries |
EP1277835A1 (en) * | 2001-07-19 | 2003-01-22 | Libragen | Methods of creating genetic diversity |
US20030129203A1 (en) * | 2001-08-27 | 2003-07-10 | Nautilus Biotech S.A. | Mutant recombinant adeno-associated viruses |
US7647184B2 (en) * | 2001-08-27 | 2010-01-12 | Hanall Pharmaceuticals, Co. Ltd | High throughput directed evolution by rational mutagenesis |
NZ532027A (en) | 2001-10-10 | 2008-09-26 | Neose Technologies Inc | Remodeling and glycoconjugation of peptides |
CN105131104B (en) | 2001-10-10 | 2018-11-16 | 诺和诺德公司 | The reconstruct and sugar conjugation of peptide |
US20050142658A1 (en) * | 2001-12-03 | 2005-06-30 | Short Jay M. | Chromosomal saturation mutagenesis |
TWI262083B (en) * | 2001-12-28 | 2006-09-21 | Syngenta Participations Ag | Microbially-expressed thermotolerant phytase for animal feed |
US20040009498A1 (en) * | 2002-01-14 | 2004-01-15 | Diversa Corporation | Chimeric antigen binding molecules and methods for making and using them |
WO2003068948A1 (en) | 2002-02-13 | 2003-08-21 | Dow Global Technologies Inc. | Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
AU2003213108A1 (en) * | 2002-02-15 | 2003-09-09 | Verenium Corporation | Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
US20030224404A1 (en) * | 2002-02-25 | 2003-12-04 | Manuel Vega | High throughput directed evolution of nucleic acids by rational mutagenesis |
WO2003072054A2 (en) * | 2002-02-25 | 2003-09-04 | Cabot Corporation | Custom ligand design for biomolecular filtration and purification for bioseperation |
US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
US7783428B2 (en) | 2002-03-01 | 2010-08-24 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US20030199068A1 (en) * | 2002-03-05 | 2003-10-23 | Bott Richard R. | High throughput mutagenesis screening method |
US20030171543A1 (en) * | 2002-03-05 | 2003-09-11 | Bott Richard R. | High throughput mutagenesis screening method |
WO2003078583A2 (en) | 2002-03-09 | 2003-09-25 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
EP1497418B1 (en) | 2002-04-19 | 2012-10-17 | Verenium Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
US7226771B2 (en) | 2002-04-19 | 2007-06-05 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
CA2485506C (en) * | 2002-05-17 | 2012-02-28 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
EP1543128A4 (en) * | 2002-07-18 | 2008-02-20 | Invitrogen Corp | Viral vectors containing recombination sites |
AU2003256731A1 (en) * | 2002-08-02 | 2004-02-23 | Aromagen Corporation | Methods for making (-) -menthol and oxygenated menthane compounds |
BR0313281A (en) | 2002-08-06 | 2007-07-24 | Verdia Inc | ap1 amine oxidase variants |
US20050202438A1 (en) * | 2002-09-09 | 2005-09-15 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
US20060020396A1 (en) * | 2002-09-09 | 2006-01-26 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
BRPI0314814C1 (en) | 2002-09-27 | 2021-07-27 | Xencor Inc | antibody comprising an fc variant |
US8158768B2 (en) * | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
MX295545B (en) | 2003-03-07 | 2012-02-03 | Diversa Corp | Hydrolases, nucleic acids encoding them and mehods for making and using them. |
US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
BRPI0409816B8 (en) | 2003-04-29 | 2022-12-06 | Pioneer Hi Bred Int | GLYPHOSATE-N-ACETYLTRANSFERASE (GAT) GENES, CONSTRUCTS COMPRISING THEM, BACTERIAL CELL, POLYPEPTIDE HAVING GAT ACTIVITY, AS WELL AS METHOD FOR PRODUCING A TRANSGENIC PLANT RESISTANT TO GLYPHOSATE AND METHODS FOR CONTROLLING WEEDS IN A FIELD CONTAINING A CROP |
EP1644538A4 (en) * | 2003-06-26 | 2006-11-08 | Invitrogen Corp | Methods and compositions for detecting promoter activity and expressing fusion proteins |
CA2546698A1 (en) * | 2003-11-20 | 2005-06-02 | Agency For Science, Technology And Research | Method |
EP2287341B1 (en) | 2003-12-01 | 2013-02-13 | Life Technologies Corporation | Nucleic acid molecules containing recombination sites and methods of using the same |
US7204950B2 (en) * | 2003-12-19 | 2007-04-17 | Pepsico, Inc. | Dispensing package |
ES2552053T3 (en) | 2004-02-25 | 2015-11-25 | Pioneer Hi-Bred International Inc. | New crystalline Bacillus thuringiensis polypeptides, polynucleotides, and compositions thereof |
EP2365090A1 (en) | 2004-05-21 | 2011-09-14 | The Regents of The University of California | Method for enhancing production of isoprenoid compounds |
CA2734716A1 (en) | 2004-06-09 | 2005-12-29 | Pioneer Hi-Bred International, Inc. | Plastid transit peptides |
EP2380982B1 (en) | 2004-10-27 | 2014-07-16 | The Scripps Research Institute | Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
US7998930B2 (en) * | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
CA2590245A1 (en) * | 2004-11-11 | 2006-05-18 | Modular Genetics, Inc. | Ladder assembly and system for generating diversity |
WO2006099207A2 (en) | 2005-03-10 | 2006-09-21 | Diversa Corporation | Lyase enzymes, nucleic acids encoding them and methods for making and using them |
NZ594810A (en) | 2005-03-15 | 2012-12-21 | Verenium Corp | Cellulases, nucleic acids encoding them and methods for making and using them |
US20070184472A1 (en) * | 2005-06-08 | 2007-08-09 | Toagosei Co., Ltd | Method of purifying environmental dna and method of efficiently screening for protein-encoding gene from environmental dna |
PT2314623E (en) | 2005-06-21 | 2012-10-02 | Xoma Technology Ltd | Il-1beta binding antibodies and fragments thereof |
GB2432366B (en) * | 2005-11-19 | 2007-11-21 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
WO2007092314A2 (en) | 2006-02-02 | 2007-08-16 | Verenium Corporation | Esterases and related nucleic acids and methods |
DK2450439T3 (en) | 2006-02-10 | 2014-02-10 | Verenium Corp | Cellulose-degrading enzymes, nucleic acids encoding them, and methods of preparing and utilizing them |
EP2548955A1 (en) | 2006-02-14 | 2013-01-23 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
EP2112227B1 (en) | 2006-03-07 | 2013-05-15 | Cargill, Incorporated | Aldolases, nucleic acids encoding them and methods for making and using them |
KR101588539B1 (en) | 2006-03-07 | 2016-01-25 | 바스프 엔자임스 엘엘씨 | Aldolases, nucleic acids encoding them and methods for making and using them |
AU2007249160B2 (en) | 2006-05-15 | 2013-09-12 | I2 Pharmaceuticals, Inc. | Neutralizing antibodies to influenza viruses |
AR061365A1 (en) * | 2006-06-13 | 2008-08-20 | Athenix Corp | METHODS TO GENERATE GENETIC DIVERSITY THROUGH MUTAGENESIS WITH PERMUTATIONS |
BRPI0714876B1 (en) | 2006-08-04 | 2022-04-19 | Verenium Corporation | Isolated, synthetic or recombinant nucleic acid, expression cassette, cloning vector or vehicle, transformed bacterial, fungal or yeast cell, isolated, synthetic or recombinant polypeptide, composition, as well as production methods and uses thereof |
CN113789316A (en) | 2006-09-21 | 2021-12-14 | 巴斯夫酶有限责任公司 | Phytases, nucleic acids encoding them and methods of making and using them |
WO2008036863A2 (en) | 2006-09-21 | 2008-03-27 | Verenium Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
US8465741B2 (en) | 2006-12-20 | 2013-06-18 | Mmrglobal, Inc. | Antibodies and methods for making and using them |
CA2673525C (en) | 2006-12-21 | 2017-12-05 | Verenium Corporation | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
CA2674721C (en) | 2007-01-30 | 2018-04-03 | Verenium Corporation | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
EP2139515B2 (en) | 2007-03-30 | 2023-12-20 | The Research Foundation of the State University of New York | Attenuated viruses useful for vaccines |
ES2701883T3 (en) * | 2007-07-31 | 2019-02-26 | Basf Enzymes Llc | Assembling custom-made multiple site combinations |
WO2009045627A2 (en) | 2007-10-03 | 2009-04-09 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
EP2219469B1 (en) | 2007-12-03 | 2017-08-30 | Syngenta Participations AG | Engineering enzymatically susceptible proteins |
US20110039722A1 (en) * | 2007-12-31 | 2011-02-17 | Xoma Technology Ltd. | Libraries, arrays and their uses for targeted affinity enhancement |
US8541220B2 (en) | 2008-01-03 | 2013-09-24 | Verenium Corporation | Isomerases, nucleic acids encoding them and methods for making and using them |
JP5563990B2 (en) | 2008-01-03 | 2014-07-30 | ヴェレニウム コーポレイション | Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
CA2712964A1 (en) * | 2008-01-28 | 2009-08-06 | Wilfred Jefferies | Tapasin augmentation for enhanced immune response |
JP2011516423A (en) | 2008-03-28 | 2011-05-26 | シー レーン バイオテクノロジーズ, エルエルシー | Neutralizing molecules against viral antigens |
CA2763790C (en) * | 2008-05-30 | 2016-11-22 | Massachusetts Institute Of Technology | Compositions and methods for spatial separation and screening of cells |
US8383346B2 (en) * | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
US20090312196A1 (en) * | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US8198062B2 (en) * | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
MX2011005815A (en) * | 2008-12-02 | 2011-09-30 | Consejo Nac Invest Cient Tec | Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof. |
US20120190071A1 (en) | 2009-05-12 | 2012-07-26 | Council Of Scientific & Industrial Research | Lipa and its variant useful for biofuel production |
CN102459303B (en) | 2009-05-21 | 2016-06-29 | 巴斯夫酶有限责任公司 | Phytase, the nucleic acid encoding them and preparation and their method of use |
ES2652340T3 (en) | 2009-07-17 | 2018-02-01 | Bioatla Llc | Simultaneous and integrated selection and evolution of performance and expression of human proteins in production hosts |
UA109884C2 (en) | 2009-10-16 | 2015-10-26 | A POLYPEPTIDE THAT HAS THE ACTIVITY OF THE PHOSPHATIDYLINOSYTOL-SPECIFIC PHOSPHOLIPASE C, NUCLEIC ACID, AND METHOD OF METHOD | |
UA111708C2 (en) | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | METHOD OF OIL REFINING |
WO2011109726A2 (en) * | 2010-03-05 | 2011-09-09 | Bioatla Llc | Homologous multi-specific antibodies |
CA2804746C (en) | 2010-07-16 | 2022-01-11 | Jay M. Short | Novel methods of protein evolution |
EP2603591A1 (en) | 2010-08-13 | 2013-06-19 | Pioneer Hi-Bred International Inc. | Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity |
BR112013008347A2 (en) | 2010-10-06 | 2016-06-14 | Bp Corp North America Inc | cbh variant polypeptides i |
US20140199682A1 (en) | 2010-11-17 | 2014-07-17 | Sea Lane Biotechnologies, Llc | Influenza neutralizing agents |
US20140182011A1 (en) | 2011-11-03 | 2014-06-26 | The University Of Hong Kong | Methods Using Acyl-Coenzyme A-Binding Proteins to Enchance Drought Tolerance in Genetically Modified Plants |
CN104540939A (en) | 2012-03-16 | 2015-04-22 | Bp北美公司 | Polypeptides having endoglucanase activity |
WO2013166113A1 (en) | 2012-05-04 | 2013-11-07 | E. I. Du Pont De Nemours And Company | Compositions and methods comprising sequences having meganuclease activity |
JP6267689B2 (en) | 2012-05-10 | 2018-01-24 | バイオアトラ、エルエルシー | Multispecific monoclonal antibody |
JP6616687B2 (en) | 2012-08-16 | 2019-12-04 | バングラデシュ ジュート リサーチ インスティテュート | Cellulose and / or hemicellulose-degrading enzyme derived from Macrophominaphaseolina and use thereof |
DK2885407T3 (en) | 2012-08-16 | 2018-07-16 | Bangladesh Jute Res Institute | DESTROYING ENZYMES FROM MACROPHOMINA PHASEOLINA AND ITS APPLICATIONS |
US10253325B2 (en) | 2012-12-19 | 2019-04-09 | Boston Medical Center Corporation | Methods for elevating fat/oil content in plants |
SG11201505977RA (en) | 2013-01-31 | 2015-08-28 | Codexis Inc | Methods, systems, and software for identifying bio-molecules using models of multiplicative form |
GB201308828D0 (en) | 2013-03-12 | 2013-07-03 | Verenium Corp | Phytase |
BR112015023286A2 (en) | 2013-03-14 | 2018-03-06 | Arzeda Corp | recombinant polypeptide with dicamba decarboxylase activity, polynucleotide construct, cell, method of producing a host cell comprising a heterologous polynucleotide encoding a dicamba decarboxylase activity, method for decarboxylating dicamba, a dicamba derivative or a dicamba metabolite, method for detecting a polypeptide and method for detecting the presence of a polynucleotide encoding a polypeptide having dicamba decarboxylase activity |
US20140287419A1 (en) | 2013-03-14 | 2014-09-25 | Arzeda Corp. | Compositions Having Dicamba Decarboxylase Activity and Methods of Use |
GB201308843D0 (en) | 2013-03-14 | 2013-07-03 | Verenium Corp | Phytase formulation |
JP2016525354A (en) | 2013-07-25 | 2016-08-25 | ビーエーエスエフ エンザイムズ エルエルシー | Phytase |
CA2935577C (en) | 2014-01-07 | 2023-04-04 | Bioatla, Llc | Proteins targeting orthologs |
US20180291413A1 (en) | 2015-10-06 | 2018-10-11 | Thermo Fisher Scientific Geneart Gmbh | Devices and methods for producing nucleic acids and proteins |
CN108697116A (en) | 2015-10-30 | 2018-10-23 | 贝丝以色列女执事医疗中心 | For measuring the bioactivity of the cereal starch enzyme trypsin inhibitor in cereal, flour, plant and complex food, amount, removing or the method for inactivation |
BR112019013402A2 (en) | 2016-12-28 | 2020-03-03 | Invvax, Inc. | INFLUENCE VACCINES |
CA3076578A1 (en) | 2017-10-25 | 2019-05-02 | Basf Se | Beta-amylase enzymes |
WO2019126211A1 (en) * | 2017-12-20 | 2019-06-27 | Basf Se | Gene site saturation mutagenesis (gssm) method |
CN112368375A (en) | 2018-04-26 | 2021-02-12 | 巴斯夫欧洲公司 | Lipase enzyme |
WO2019211143A1 (en) | 2018-05-03 | 2019-11-07 | Basf Se | Amylase enzymes |
EP3802813A1 (en) | 2018-05-29 | 2021-04-14 | Basf Se | Amylase enzymes |
CN112969792A (en) | 2018-09-07 | 2021-06-15 | 巴斯夫植物科学有限公司 | Improved methods for producing high levels of PUFAs in plants |
WO2020049157A1 (en) | 2018-09-07 | 2020-03-12 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of pufa in plants |
US20210317467A1 (en) | 2018-09-07 | 2021-10-14 | Basf Plant Science Copmany Gmbh | Improved method for the production of high levels of pufa in plants |
EP3938504A1 (en) | 2019-03-11 | 2022-01-19 | Basf Se | Amylases and methods for making and using them |
EP3958890A4 (en) | 2019-04-23 | 2023-05-03 | Basf Se | Beta-amylase variants |
EP4077658A1 (en) | 2019-12-20 | 2022-10-26 | Basf Se | Decreasing toxicity of terpenes and increasing the production potential in micro-organisms |
EP4162061A1 (en) | 2020-06-04 | 2023-04-12 | Isobionics B.V. | Synthetic santalene synthases |
EP4015626A1 (en) | 2020-12-18 | 2022-06-22 | Isobionics B.V. | Enzymes and methods for fermentative production of monoterpene esters |
WO2023012111A2 (en) | 2021-08-02 | 2023-02-09 | Basf Se | Novel production of aroma compounds with ionylideneethane synthases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959312A (en) * | 1985-05-31 | 1990-09-25 | The University Of Tennessee Research Corporation | Full spectrum mutagenesis |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
DE768377T1 (en) | 1988-09-02 | 1998-01-02 | Dyax Corp | Production and selection of recombinant proteins with different binding sites |
US5096815A (en) | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
US5198346A (en) | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
DE69333243T2 (en) | 1992-11-24 | 2004-08-19 | G.D. Searle & Co., Chicago | MUTTED INTERLEUKIN-3 (IL-3) POLYPEPTIDES |
WO1995010603A1 (en) * | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
US6187579B1 (en) | 1993-10-28 | 2001-02-13 | Carlsberg A/S | Customized proteases |
US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
US5389537A (en) | 1994-01-21 | 1995-02-14 | Wisconsin Alumni Research Foundation | Nuclease having altered specificity |
AU3330895A (en) | 1994-08-18 | 1996-03-14 | Cytogen Corporation | Peptide librairies as a source of syngenes |
CA2200684A1 (en) | 1994-09-21 | 1996-03-28 | Cytogen Corporation | Antigen binding peptides (abtides) from peptide libraries |
US5885577A (en) | 1994-09-21 | 1999-03-23 | Cytogen Corporation | Antigen binding peptides (abtides) from peptide libraries |
WO1996041865A1 (en) | 1995-06-07 | 1996-12-27 | Ariad Gene Therapeutics, Inc. | Rapamcycin-based regulation of biological events |
US5789166A (en) | 1995-12-08 | 1998-08-04 | Stratagene | Circular site-directed mutagenesis |
US5885827A (en) | 1996-01-23 | 1999-03-23 | The Regents Of The Universtiy Of California | Eukaryotic high rate mutagenesis system |
EP0973804B1 (en) | 1997-04-07 | 2006-12-27 | Genentech, Inc. | Anti-vegf antibodies |
EA199900947A1 (en) | 1997-04-18 | 2000-04-24 | Байоджен, Инк. | HYBRID PROTEINS TGF-BETA II TYPE / CONSTANT AREA OF IMMUNOGLOBULIN |
AU7171098A (en) | 1997-05-01 | 1998-11-24 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
EP1032683B1 (en) * | 1997-11-17 | 2005-02-02 | Novozymes Biotech, Inc. | Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
EP1042457B1 (en) * | 1997-12-16 | 2006-03-08 | Novozymes A/S | Polypeptides having aminopeptidase activity and nucleic acids encoding same |
CA2318402A1 (en) | 1998-01-15 | 1999-07-22 | Ariad Gene Therapeutics, Inc. | Regulation of biological events using multimeric chimeric proteins |
-
1999
- 1999-02-04 US US09/246,178 patent/US6171820B1/en not_active Expired - Lifetime
-
2000
- 2000-02-04 CA CA002325351A patent/CA2325351C/en not_active Expired - Fee Related
- 2000-02-04 AU AU34839/00A patent/AU3483900A/en not_active Abandoned
- 2000-02-04 WO PCT/US2000/003086 patent/WO2000046344A2/en active Search and Examination
- 2000-02-04 JP JP2000597406A patent/JP2003524392A/en active Pending
-
2005
- 2005-03-18 JP JP2005080273A patent/JP2005245453A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959312A (en) * | 1985-05-31 | 1990-09-25 | The University Of Tennessee Research Corporation | Full spectrum mutagenesis |
Non-Patent Citations (3)
Title |
---|
CWIRLA ET AL.: "Peptides on phage: A vast library of peptides for identifying ligands", PROC. NATL. ACAD. SCI. USA,, vol. 87, August 1990 (1990-08-01), pages 6378 - 6382, XP000141872 * |
HILL ET AL.: "Mutagenesis with degenerate oligonucleotides: An efficient method for saturating a defined DNA region with base pair substitutions", METHODS IN ENZYMOLOGY,, vol. 155, 1987, pages 558 - 569, XP002929872 * |
MURRAY ET AL.: "Saturation mutagenesis of a major histocompatibility complex protein domain: Identification of a single conserved amino acid important for allorecognition", PROC. NATL. ACAD. SCI. USA,, vol. 85, May 1988 (1988-05-01), pages 3535 - 3539, XP002929873 * |
Also Published As
Publication number | Publication date |
---|---|
US6171820B1 (en) | 2001-01-09 |
CA2325351C (en) | 2005-02-01 |
WO2000046344A2 (en) | 2000-08-10 |
AU3483900A (en) | 2000-08-25 |
CA2325351A1 (en) | 2000-08-10 |
JP2005245453A (en) | 2005-09-15 |
JP2003524392A (en) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000046344A3 (en) | Non-stochastic generation of genetic vaccines and enzymes | |
EP2397549A3 (en) | Non-stochastic generation of genetic vaccines and enzymes | |
WO2000053744A3 (en) | End selection in directed evolution | |
WO1999041369A3 (en) | Genetic vaccine vector engineering | |
EP1385370A4 (en) | Animicrobial polypeptides and their uses | |
MXPA04011937A (en) | Immunostimulatory oligonucleotides and uses thereof. | |
AU2001254624A1 (en) | Human coagulation factor vii variants | |
WO2002074798A3 (en) | The genome of a bifidobacterium | |
MXPA02006888A (en) | Recombinant flaviviruses and methods of use thereof. | |
WO2001019859A3 (en) | LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE | |
MXPA02012937A (en) | Combinations of active ingredients, which exhibit insecticidal and acaricidal properties. | |
WO1999057282A3 (en) | Pesticidal toxins and nucleotide sequences which encode these toxins | |
WO2003076561A3 (en) | Recombinase fusion protein with enhanced cellular uptake | |
WO2000053776A3 (en) | Human kallikrein-like genes | |
WO2001087350A3 (en) | Treatment of human papillomavirus (hpv)-infected cells | |
AU8491401A (en) | Phage-dependent superproduction of biologically active protein and peptides | |
EP1613345A4 (en) | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 | |
WO2004072225A3 (en) | Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi | |
WO2002012468A3 (en) | 2,5-dkg permeases | |
WO2003093298A3 (en) | Immunogenic peptides | |
SG128684A1 (en) | Novel sequence and utilization thereof | |
DE50011695D1 (en) | Expression system for the production of proteins in fungi | |
YU8402A (en) | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins | |
WO2002000844A3 (en) | Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use | |
ATE293170T1 (en) | PHAGE-DEPENDENT SUPERPRODUCTION OF BIOLOGICALLY ACTIVE PROTEINS AND PEPTIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 138206 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2325351 Country of ref document: CA |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/009723 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000913378 Country of ref document: EP Ref document number: 34839/00 Country of ref document: AU |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 2000913378 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |